View & Sign our petition Between August 27 and December 25, 2018, we are collecting e-signatures on the Government of Canada’s official website for petitions. Our petition is called “E-1819 (Hypothyroidism)” and is available at this link: https://petitions.ourcommons.ca/en/Petition/Details?Petition=e-1819 The petition… Read More ›
Another great study by McAninch and colleagues, from Antonio Bianco’s lab, has been published in a leading endocrinology journal, The Journal of Clinical Endocrinology & Metabolism. The study was announced and summarized in this press release titled “Standard Hypothyroidism Treatment… Read More ›
Do you know about the effects of the two kinds of T2 thyroid hormone that your body produces? A significant 2017 mouse study examined treatment with T3 as well as two types of T2 hormone. One type of T2 is… Read More ›
Published August 2018, a new study of T4 and T3 hormones and obesity in relation to breast cancer risk found that higher levels of T4 hormone conferred greater risk, while higher T3 levels had a protective effect. The article Ortega-Olvera,… Read More ›
The co-discoverers of the T3 hormone (triiodothyronine) in 1952 were Rosalind Pitt-Rivers, MD, PhD (London) and Dr. Jack Gross, MD, PhD (McGill) from Canada. Rosalind Pitt-Rivers’ early life Dr. Jamshed Tata, one of Pitt-Rivers’ many co-authors, wrote the Biographical… Read More ›
In 2016, Dr. Elizabeth McAninch and Dr. Antonio Bianco published a research paper called “The History and Future of Treatment with Hypothyroidism.” On Dr. Bianco’s research team’s website, deiodinase.org, there is a blog post about this study that includes a… Read More ›